LP-65 is a dual-function inhibitor that targets both MEK (IC50=83.2 nM) and mTOR (IC50=40.5 nM). It disrupts the MEK and mTOR signaling pathways, effectively inhibiting the proliferation and migration of tumor cells. LP-65 shows potential for use in cancer research.
Target-Kategorie:
mTOR|||MEK
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
